Related Experiment Video

Updated: Aug 24, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

What indication is common to different genotoxicity data bases?

R Benigni1, A Giuliani

  • 1Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, Rome, Italy.

Mutation Research
|October 1, 1991
PubMed

Insights

This study reveals consistent relationships among four in vitro mutagenicity assays across multiple databases. The Salmonella mutation assay (STY) and chromosomal aberrations in CHO cells (CHA) show similar chemical responses, as do mouse lymphoma assays (MLY) and sister-chromatid exchanges (SCE).

Area of Science:

  • Toxicology
  • Genetics
  • In vitro toxicology

Background:

  • Understanding the relationships between different in vitro genotoxicity assays is crucial for accurate chemical safety assessment.
  • Existing data from major international programs provide a valuable resource for comparative analysis.

Purpose of the Study:

  • To analyze the interrelationships among four key in vitro genotoxicity assays: Salmonella mutation (STY), mouse lymphoma L5178Y cell mutation (MLY), chromosomal aberrations in CHO cells (CHA), and sister-chromatid exchanges in CHO cells (SCE).
  • To identify common patterns and 'true' relationships among these assays, independent of specific database characteristics, using factor analysis.

Main Methods:

  • Factor analysis was applied to data from three major databases: U.S. National Toxicology Program (NTP), International Program for the Evaluation of Short-Term Tests for Carcinogens (IPESTTC), and International Program on Chemical Safety (IPCS).
  • This statistical approach allowed for the separation of database-specific effects from common underlying relationships among the assays.

Main Results:

  • A significant common factor, representing 'true' assay relationships, was identified across all databases, explaining substantial variance (69% in NTP, 50% in IPESTTC, 30% in IPCS).
  • Consistent similarities were observed between the Salmonella mutation assay (STY) and chromosomal aberrations in CHO cells (CHA), despite their different biological endpoints.
  • A second consistent similarity was found between mouse lymphoma cell mutation assays (MLY) and sister-chromatid exchanges in CHO cells (SCE).

Conclusions:

  • The convergence of evidence across major comparative studies on in vitro genotoxicity assays is reassuring for the field.
  • These findings highlight the need for further research to elucidate the mechanisms underlying the observed assay relationships and their implications for predicting chemical mutagenicity.

More Related Videos

The Lambda Select cII Mutation Detection System07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...